Discover · The Research Behind It

Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline — Pottie et al., Can Fam Physician 2018

Last checked

  • Free
  • Worldwide
  • Research paper
  • Reading
  • Online

Never stop or reduce a prescribed medicine on your own: some medicines cause withdrawal effects or a relapse if they are stopped or cut down too quickly. Use these resources to plan it with your prescriber.

Published in
Canadian Family Physician, 2018
Evidence
Moderate
Cost
Free.

What is this paper about?

This deprescribing.org guideline recommends offering a slow taper to adults aged 65 or over who take benzodiazepines or Z-drugs for insomnia, whatever the duration of use (strong recommendation, low-quality evidence), and suggests the same for adults aged 18 to 64 who have used them for over four weeks (weak recommendation). Its review found tapering improved stopping rates over usual care without serious harms; it advises involving patients in the tapering plan.

Why is it in the directory?

Backs up deprescribing.org and the Canadian Deprescribing Network in chapter 06, the slow-tapering approach the Benzodiazepine Information Coalition promotes, and the CBT-I programmes and sleep books in chapters 10 and 11, as the guideline pairs tapering with behavioural sleep advice.

Is it free to read?

Evidence-based clinical practice guideline (GRADE) with a systematic review of benzodiazepine and Z-drug deprescribing trials for insomnia. Moderate evidence. Can Fam Physician 2018;64(5):339–351. Free full text in PubMed Central (PMC5951648).

About the paper

Authors
Pottie K, Thompson W, Davies S, et al.
Published in
Can Fam Physician 2018;64(5):339–351
Kind of study
Evidence-based clinical practice guideline (GRADE) with a systematic review of benzodiazepine and Z-drug deprescribing trials for insomnia
Strength of evidence
Moderate — good studies, but fewer of them or with some limits
Free to read
Free in PMC (© College of Family Physicians of Canada)

Good to know

  • The evidence was rated low quality, and it covers insomnia only, not benzodiazepines taken for anxiety or other conditions.

Where it sits in the directory

Listed under “Coming Off Medication Safely — Tapering & Deprescribing” in chapter 17 of the directory, The Research Behind It, with 12 other listings in the same category.

See every listing in “Coming Off Medication Safely”

Similar listings

Also in the directory, with why each one is here.

Browse all 280 in The Research Behind It

This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.